Personalized Strategies to Reduce Cancer Overtreatment

Major Changes Urged for Cancer Screening and Treatment — Scientific Panel Recommends New Personalized Strategies to Reduce Cancer Overtreatment – To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”

Cancer patients vulnerable to financial stress and bankruptcy

Cancer diagnosis puts people at greater risk for bankruptcy — Study also shows younger cancer patients are most vulnerable to financial stress – People diagnosed with cancer are more than two-and-a-half times more likely to declare bankruptcy than those without cancer. Younger cancer patients had two- to five-fold higher bankruptcy rates compared to older patients, and that overall bankruptcy filings increased as time passed following diagnosis.

Generic version of cancer drug Doxil approved

FDA approval of generic version of cancer drug Doxil is expected to help resolve shortage – The U.S. Food and Drug Administration approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection). Doxorubicin hydrochloride liposome injection is currently on the FDA?s drug shortage list.

Multivitamins reduce risk of cancer in men

Daily multivitamins reduce risk of cancer in men — Brigham and Women?s Hospital study is the first to examine the long-term affect of multivitamins on a major chronic diseases – A daily multivitamin can help a man reduce his risk of cancer. The Physicians’ Health Study II is the first clinical trial to test the affects of multivitamins on a major disease such as cancer.

Do NOT follow this link or you will be banned from the site!